Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.88 USD | -2.34% | -0.52% | +44.73% |
Financials (USD)
Sales 2024 * | 6.39B | Sales 2025 * | 6.47B | Capitalization | 5.5B |
---|---|---|---|---|---|
Net income 2024 * | 751M | Net income 2025 * | 971M | EV / Sales 2024 * | 2.06 x |
Net Debt 2024 * | 7.64B | Net Debt 2025 * | 6.93B | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
7.37
x | P/E ratio 2025 * |
5.7
x | Employees | 10,000 |
Yield 2024 * |
5.2% | Yield 2025 * |
5.41% | Free-Float | 99.84% |
Latest transcript on Organon & Co.
1 day | +0.23% | ||
1 week | +1.86% | ||
Current month | +0.23% | ||
1 month | +9.03% | ||
3 months | +21.75% | ||
6 months | +85.91% | ||
Current year | +48.27% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Ali
CEO | Chief Executive Officer | 63 | 21-06-01 |
Matthew Walsh
DFI | Director of Finance/CFO | 57 | 21-06-01 |
Chief Tech/Sci/R&D Officer | 54 | 23-09-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rochelle Lazarus
BRD | Director/Board Member | 76 | 21-06-01 |
Carrie Cox
CHM | Chairman | 66 | 21-06-01 |
Robert Essner
BRD | Director/Board Member | 76 | 21-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.92% | 254 M€ | +13.33% | - | |
1.71% | 2 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 20.87 | -2.39% | 734 191 |
24-06-03 | 21.38 | +0.23% | 1,290,383 |
24-05-31 | 21.33 | +1.86% | 1,980,996 |
24-05-30 | 20.94 | +1.80% | 1,782,985 |
24-05-29 | 20.57 | -1.95% | 1,447,206 |
Delayed Quote Nyse, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.27% | 5.5B | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- OGN Stock